BDBM303011 (2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(2-ethyl- 3-oxoisoindolin-5-yl)- 4-fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 23::US9598446, Compound 23
SMILES: CCN1Cc2ccc(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3cc(C(C)=O)c4cc(Nc5cncnc5)ccc34)cc2C1=O
InChI Key: InChIKey=ATPSKHFIIPPEIS-NGOKVRLYSA-N
Data: 2 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Complement factor D (Homo sapiens (Human)) | BDBM303011 ((2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US10660876 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM303011 ((2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ACHILLION PHARMACEUTICALS, INC. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9598446 (2017) BindingDB Entry DOI: 10.7270/Q2ST7RWF | |||||||||||
More data for this Ligand-Target Pair |